Representatives from the Mideast’s travel industry are closely watching their news feeds for any updates on the World Health Organization’s impending decision as to whether or not to grant emergency use approval to Chinese-made COVID-19 vaccines Sinopharm and Sinovac.
Currently, the European Union will only permit tourists from outside the bloc who’ve been inoculated with an approved vaccine. Travel industry leaders in the Persian Gulf and Mideast regions are hopeful Brussels will soon extend that to also include jabs validated by the WHO as well — and given the widespread use of Sinopharm in the region, that could potentially be the catalyst to get people traveling again between EU and GCC countries.
